| Project/Area Number |
23650621
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Clinical oncology
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
OUCHI Noriaki 東北大学, 大学院・医学系研究科, 教授 (90203710)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
GONDA Kosuke 東北大学, 大学院・医学系研究科, 准教授 (80375435)
AMARI Masakazu 東北大学, 大学院・医学系研究科, 准教授 (50400312)
TADA Hiroshi 東北大学, 大学院・医学系研究科, 助教 (50436127)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | ドラッグデリバリー / 癌 / バイオテクノロジー / 薬学 |
|---|
| Research Abstract |
We prepared GFP-fused EB1-expressing human breast cancer cells. The growth rate of the microtubule plus-end was measured using the positions of EB1 assembly over time. Analysis of the dynamics of the EB1-GFP comet showed that the microtubule growth rates decreased when the cells were treated with anticancer drugs. We also measured the microtubule growth rates in tumor-bearing mice by using an original stereotaxic instrument. Thus, alteration in EB1-GFP dynamics is an effective indicator for the effects of anticancer drugs.
|
